ARG1 (Arginase-1, human, UniProtKB:P05089) — review notes

Summary of function

ARG1 is the cytosolic, liver-type (type I) arginase, a binuclear manganese
metalloenzyme that catalyzes the terminal (fifth) step of the urea cycle:
L-arginine + H2O -> L-ornithine + urea (EC 3.5.3.1). It regenerates ornithine to
close the cycle and produces the urea that is excreted. It is a homotrimer, each
subunit binding two Mn(2+) ions. Beyond hepatic ureagenesis, ARG1 is
constitutively expressed in neutrophil granules and released during inflammation,
where local arginine depletion suppresses T-cell (and NK-cell) proliferation /
cytokine production — a myeloid immunoregulatory role. Loss-of-function variants
cause argininemia / arginase deficiency, a urea cycle disorder distinguished by
progressive spastic diplegia/paraparesis rather than the neonatal hyperammonemic
crises typical of proximal UCDs.

Key verbatim citations

Disease (dismech Arginase_Deficiency.yaml)

"progressive spastic diplegia or paraparesis, seizures, intellectual disability,
and growth retardation... relatively infrequent hyperammonemia compared to other
urea cycle disorders." Neurotoxicity from arginine + guanidino compounds.

GO term-definition checks (OLS)

Deep research

falcon deep-research launched (just deep-research-falcon human P05089 --alias ARG1);
FAILED after 600s ("All providers failed" — falcon endpoint timeout). No
-deep-research-falcon.md file produced. Review grounded in the UniProt record, all 9
cached publications, and dismech Arginase_Deficiency.yaml. No DR file fabricated.